financetom
Business
financetom
/
Business
/
Computer parts maker Logitech raises 2025 sales forecast on strong demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Computer parts maker Logitech raises 2025 sales forecast on strong demand
Jan 28, 2025 2:34 PM

ZURICH, Jan 28 (Reuters) - Logitech International

raised its full-year forecast on Tuesday, after

reporting higher sales and profit for its important pre-holiday

quarter, supported by strong demand for computer hardware

products for businesses and gamers.

The Swiss-American company, which makes products such as

keyboards, mouse and webcams, said its sales rose nearly 7% to

$1.34 billion in what is traditionally its "biggest quarter of

the year". That compares with the consensus estimate of $1.25

billion, according to Visible Alpha.

Its adjusted operating profit for the third quarter ended

December also rose 7% to $266 million.

Logitech CEO Hanneke Faber said gaming sales were "near

pandemic-high levels" thanks to a series of launches ahead of

the holidays. "We delivered near record sales in our premium Pro

Gaming and MX portfolios."

The company now expects its fiscal 2025 sales in the range

of $4.54 billion to $4.57 billion, compared with its previous

forecast of $4.39 billion to $4.47 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Delta Air Lines' Flight Incident With Air Force Jets Leads to NTSB Inquiry
Market Chatter: Delta Air Lines' Flight Incident With Air Force Jets Leads to NTSB Inquiry
Mar 31, 2025
12:00 PM EDT, 03/31/2025 (MT Newswires) -- Delta Air Lines ( DAL ) shares were lower Monday after the National Transportation Safety Board said it will investigate a close call that took place between a Delta flight and US Air Force jets near Reagan Washington National Airport on Friday, Reuters reported, citing the regulator. The Delta Airbus A319 received a...
Genmab Says European Commission Grants Marketing Authorization for Tivdak as Cervical Cancer Treatment
Genmab Says European Commission Grants Marketing Authorization for Tivdak as Cervical Cancer Treatment
Mar 31, 2025
12:00 PM EDT, 03/31/2025 (MT Newswires) -- Genmab ( GMAB ) said Monday that the European Commission has granted marketing authorization for Tivdak as a treatment for adult patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy. The company said the approval was based on data from a phase 3 trial that met its...
Update: Largo Drops 9% as It Q4 Loss Narrows; Details Operational Turnaround Plan and Optimization Initiatives
Update: Largo Drops 9% as It Q4 Loss Narrows; Details Operational Turnaround Plan and Optimization Initiatives
Mar 31, 2025
12:00 PM EDT, 03/31/2025 (MT Newswires) -- (Updates shares.) Largo (LGO.TO) late on Friday reported that its fourth-quarter loss narrowed even as revenue fell. The company said it lost US$13 million, or US$0.19 per share, narrowing from a loss of US$13.3 million, or US$13.3 million, in the year-prior quarter Revenue came in at US$24.3 million, down from US$44.2 million. The...
BridgeBio Pharma Says Acoramidis Improves Outcomes in Phase 3 ATTR-CM Trial
BridgeBio Pharma Says Acoramidis Improves Outcomes in Phase 3 ATTR-CM Trial
Mar 31, 2025
12:00 PM EDT, 03/31/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Monday acoramidis showed statistically significant improvements in clinical outcomes in both variant and wild-type transthyretin amyloid cardiomyopathy, or ATTR-CM, in a phase 3 trial. The study compared acoramidis with placebo for time to all-cause mortality or first cardiovascular-related hospitalization in both variant and wild-type ATTR-CM, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved